Signaling Pathways
| Product Name | CAS No. | Specification | Application | Registration |
| 24, 25-Dihydroxy VD3 | 40013-87-4 | |||
| Retatrutide | 2381089-83-2 | 98+% | Research on Obesity | GLP Receptor | |
| Ruxolitinib phosphate | 1092939-17-7 | 99+% | ||
| Hidrosmin | 115960-14-0 | 90+% | Research on Venous Insufficiency and Diabetes | |
| Azvudine | 1011529-10-4 | 98+% | Reverse Transcriptase | |
| Fludarabine Phosphate | 75607-67-9 | 98+% | DNA/RNA Synthesis inhibitor | |
| Fludarabine | 21679-14-1 | 98+% | Antineoplastic Agents | |
| Azacitidine | 320-67-2 | 98+% | DNA Methyltransferase | |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | 98+% | Antifolate | |
| Carfilzomib | 868540-17-4 | 98+% | Proteasome inhibitor | Autophagy activator | Apoptosis related activator | |
| Darolutamide | 1297538-32-9 | 98+% | Androgen Receptor | |
| Resmetirom | 920509-32-6 | 98+% | Thyroid Hormone Receptor | |
| Pirarubicin | 72496-41-4 | 98+% | Topoisomerase | Antibacterial | Antibiotic | Autophagy | |
| Valrubicin | 56124-62-0 | 98+% | PKC inhibitor | |
| Iclepertin | 1421936-85-7 | 98+% | GlyT inhibitor |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn